Compare Heron Therapeutics Inc (HRTX) vs Sirius XM Holdings Inc (SIRI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Sirius XM Holdings Inc — how do they compare? Heron Therapeutics Inc trades at $0.47 (market cap $91.46M), while Sirius XM Holdings Inc trades at $30.19 (market cap $10.30B). The key difference: Sirius XM Holdings Inc is far larger — about 112.6× Heron Therapeutics Inc's market cap, and Sirius XM Holdings Inc pays a 3.53% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | SIRI | |
|---|---|---|
Market Cap | $91.46M | $10.30B |
Sector | Health | Media |
52-Week High | $1.96 | $31.22 |
52-Week Low | $0.39 | $19.92 |
Enterprise Value | $189.36M | $19.97B |
Dividend Yield | — | 3.53% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HRTX trades at $0.4804, up 2.06% today, with a bullish technical signal despite mixed earnings. The stock shows a low price-to-sales ratio of 0.51 but negative profitability, with a net income margin of -20.53% in 2026. Recent Q1 2026 earnings missed expectations, though management reaffirmed full-year guidance. Analyst consensus is strongly bullish with 94.7% buy ratings.
Outlook remains speculative given persistent losses and cash burn, but potential upside exists if operational improvements materialize. Key risks include patent litigation outcomes and reliance on revenue growth to achieve profitability. Investors should weigh high analyst optimism against fundamental challenges.
Sirius XM (SIRI) trades at $30.68, up 0.29% with a bullish technical signal and strong analyst support (58% buy ratings). The company shows improving fundamentals with three consecutive quarterly earnings beats and a return to profitability in 2025 after a 2024 loss. Recent developments include a strategic advertising partnership with YouTube and potential inclusion in the S&P MidCap 400 index.
The stock presents value characteristics with a P/E of 12.96 and P/B of 0.88, trading near the consensus price target of $31.17. Key risks include competitive pressures in media streaming and high debt levels despite recent improvement. Revenue stabilization and new partnerships provide catalysts, though execution risks remain in a challenging advertising environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Sirius XM Holdings Inc
SiriusXM Holdings is now composed of two businesses: SiriusXM and Pandora. SiriusXM transmits music, talk shows, sports, and news via its two satellite radio networks, primarily to consumers in vehicles who pay a subscription fee. The firm's radios come preinstalled on a wide range of light vehicles in the U.S. and Canada. The firm acquired Pandora Media in February 2019 via an all-stock transaction. Pandora is a streaming music platform that offers an ad-supported radio option and a paid on-demand service. Liberty Media owns 80% of SiriusXM, traded through its Liberty SiriusXM Group tracking stock.
Read more on SIRI →
